Program Overview
Program Overview
IOCGE 2026 Program (Day 1)
2nd December- Morning
IOCGE 2026
Session 2. Advances in Diagnosis, Treatment, and Prevention of Genetic Disorders
Date: 2 December 2026 (Wednesday)
Time: 09:00 (CET, Basel) | 03:00 (EST, New York) | 16:00 (CST Asia, Beijing)
| Time in CET | Speaker | Title |
| 9:00–9:10 | Prof. Dr. Selvarangan Ponnazhagan Conference Chair |
Opening Remark |
| 9:10–9:15 | Prof. Dr. Emiliano Giardina Session Chair |
Welcome from the Session Chair |
| 9:15–9:35 | Prof. Dr. Gokce A Toruner Invited Speaker |
Optical Genome Mapping in Hematological Malignancies |
| 9:35-9:50 | Alba Timon-Gomez Selected Speaker |
Strategies to enhance the delivery of synthetic therapeutic oligonucleotides |
| 9:50-10:05 | Domenica Megalizzi Selected Speaker |
Combining established and emerging molecular approaches for FSHD diagnosis |
| 10:05-10:20 | Serena Maccaroni Selected Speaker |
Functional characterization of the MDPL-associated POLD1 Ser605 deletion in yeast reveals impaired Pol δ function |
| 10:20-10:35 | Maya Atanasoska Selected Speaker |
Expanding the clinical spectrum of ATP2B2-associated neurodevelopmental disorder |
| 10:35-10:50 | Anastasia Vadimovna Anurieva Selected Speaker |
Deletion in the region of the second exon and the 3'-non-coding region of the ARMS2 gene affects the risk of AMD |
| 10:50-11:05 | Luka Cvitković Selected Speaker |
Adolescent- and adult-onset biotin–thiamine-responsive basal ganglia disease (SLC19A3): a systematic review of published cases |
2nd December- Afternoon
IOCGE 2026
Session 5. Cancer Genetics
Date: 2 December 2026 (Wednesday)
Time: 15:00 (CET, Basel) | 09:00 (EST, New York) | 22:00 (CST Asia, Beijing)
| Time in CET | Speaker | Title |
| 15:00-15:05 | Dr. Xin Wang/Prof. Dr. Christos Kontos Session Chairs |
Welcome from the Session Chair |
| 15:05-15:25 | Prof. Dr. Karen M. Vasquez Invited Speaker |
Distinct mechanisms of DNA structure-induced genetic instability in cancer genomes |
| 15:25-15:40 | Yongting Luo Selected Speaker |
CircZFPM2 Encodes a Cryptic Peptide that Promotes Sorafenib Resistance in Hepatocellular Carcinoma via FZD6/Wnt Signaling |
| 15:40-15:55 | Amelia Baczyńska Selected Speaker |
Evaluation of the Influence of Relaxin-2 on Glucocorticoid Receptor Expression and Function in Androgen-Independent Prostate Cancer Cells |
| 15:55-16:10 | Olga Tselousova Selected Speaker |
Impact of the tumor microenvironment on circulating tumor DNA release in breast cancer |
| 16:10-16:25 | Yiming Xu Selected Speaker |
Systems-Level Analysis of lncRNA Regulation in Prostate Cancer: Ancestry- and Vitamin D–Associated Candidate Biomarkers |
| 16:25-16:40 | Calum Jake Ludovicus Turpie Selected Speaker |
Identification of Cell Motility-Associated Genes Linked to Invasive Prostate Cancer Phenotypes |
| 16:40-16:55 | Azam Azimi Selected Speaker |
A Neuronal-Associated Androgen-Responsive Luminal Cell State Identified in Treatment-Naïve Primary Prostate Cancer by Single-Cell Flex Profiling |
| 16:55-17:15 | Dr. Yang Yi Invited Speaker |
Crosstalk between EZH2 and m6A RNA methylation promotes prostate cancer progression through modulating an m6A autoregulation pathway |
IOCGE 2026 Program (Day 2)
3rd December- Morning
IOCGE 2026
Session 1. Non-coding RNAs in Health and Diseases
Date: 3 December 2026 (Thursday)
Time: 09:00 (CET, Basel) | 03:00 (EST, New York) | 16:00 (CST Asia, Beijing)
| Time in CET | Speaker | Title |
| 9:00-9:05 | Prof. Dr. Jyotsna Batra Session Chair |
Welcome from the Session Chair |
| 9:05–9:35 | Prof. Dr. Jyotsna Batra Keynote Speaker |
Diagnostics and therapeutic potential of miRNAs in prostate cancer |
| 9:35-9:55 | Prof. Dr. Laurent Metzinger Invited Speaker |
Non-coding RNAs in Chronic Kidney Disease: biomarkers and potential therapeutic targets |
| 9:55-10:15 | Prof. Dr. Juliet French Invited Speaker |
From genetics to potential therapeutics: Exploiting lncRNAs for breast cancer treatment |
| 10:15-10:35 | Dr. Samaneh Farashi Invited Speaker |
To be updated |
| 10:35-10:50 | Vasiliki Makri Selected Speaker |
Seasonal Expression of miR-29, miR-133 and miR-199 in the Heart and Liver of Gilthead Sea Bream (Sparus aurata): Linking Fish Health to Human Nutrition |
| 10:50-11:05 | Maria-Anna Kyrgiafini Selected Speaker |
Molecular Heterogeneity Exists within Normozoospermic Men: A Sperm Small RNA Sequencing Study |
| 11:05-11:20 | Irina Valerievna Pronina Selected Speaker |
The Role of MicroRNA-dependent Regulation in the Atypical Expression of the Epithelial-to-Mesenchymal Transition Genes in Non-Small Cell Lung Cancer |
3rd December- Afternoon
IOCGE 2026
Session 6. Applications of Machine Learning and Bioinformatics
Date: 3 December 2026 (Thursday)
Time: 15:00 (CET, Basel) | 09:00 (EST, New York) | 22:00 (CST Asia, Beijing)
| Time in CET | Speaker | Title |
| 15:00-15:05 | Prof. Dr. Hongyan Xu Session Chair |
Welcome from the Session Chair |
| 15:05-15:35 | Prof. Dr. Zhaohui S. Qin Keynote Speaker |
Computational genetics: the new frontier of genetics thanks to machine learning |
| 15:35-15:50 | Roxana Carabas Selected Speaker |
Sequence-Based Gene Ontology Prediction with ESM2 Embeddings in a CAFA 6 Setting |
| 15:50-16:05 | Daniel Valkanov Selected Speaker |
Graph Neural Network-Based Identification and Analysis of Molecular Interactions in Breast Cancer Subtypes |
| 16:05-16:20 | Felício De Freitas Netto Selected Speaker |
Predicting the diagnostic yield of exome sequencing using machine learning based on clinical and phenotypic features in a cohort of 325 patients |
| 16:20-16:35 | Gabriel Pereira Selected Speaker |
Predictive modeling of skin photoaging based on pairwise gene expression differences using ElasticNet regression |
| 16:35-16:50 | Tanisha De Selected Speaker |
Non-IID Federated Learning with CKKS Homomorphic Encryption: A Privacy-Preserving Proof-of-Concept on Real Breast Cancer Gene Expression Data |
| 16:50-17:20 | Prof. Dr. Xia Yang Keynote Speaker |
Causal and Machine-learning-assisted network modeling in disease mechanistic and drug discovery |
IOCGE 2026 Program (Day 3)
4th December- Morning
IOCGE 2026
Session 7. Population Genetics and Genetic Epidemiology
Date: 4 December 2026 (Friday)
Time: 09:00 (CET, Basel) | 03:00 (EST, New York) | 16:00 (CST Asia, Beijing)
| Time in CET | Speaker | Title |
| 9:00-9:05 | Prof. Dr. Laurent Metzinger Session Chair |
Welcome from the Session Chair |
| 9:05–9:25 | Prof. Dr. Neil Greenspan Invited Speaker |
“Gene”: One Word, Many Meanings |
| 9:25-9:40 | Umida Ashurova Selected Speaker |
CYP11B2 Aldosterone Synthase Polymorphism and Risk-Index Prediction of Hypertensive Disorders in Pregnancy: A Case-Control Study in Uzbek Women |
| 9:40-9:55 | OUMAIMA AIT TALB ALI Selected Speaker |
Diagnostic performance of APRI, FIB-4 and inflammatory indices (NLR, PLR, SII) in patients with mixed-etiology liver disease: A Moroccan case–control study |
| 9:55-10:10 | Daniel F. Faccini Selected Speaker |
Whose Genes? The structure of disagreement in the understanding of genes |
| 10:10-10:25 | Giulia Trastulli Selected Speaker |
A population-specific cumulative odds ratio score (CORS) for genetic risk stratification in sporadic Parkinson's disease |
| 10:25-10:40 | Marcos Jessé Abrahão Silva Selected Speaker |
BIOINFORMATICS INVESTIGATION AND POPULATION ANALYSIS OF THE SNP rs11209026 OF THE IL-23R GENE IN A COVID-19 COHORT OF PROFESSIONALS EXPOSED TO SARS-CoV-2 IN THE BRAZILIAN AMAZON ON 1st WAVE |
| 10:40-10:55 | Christ Ian M. Navarro Selected Speaker |
Title A Continuous-Time Finite-Island Model with Sex-Differentiated Migration and Distinct Populations for the Gene Flow Analysis of X-linked Recessive Diseases |
4th December- Afternoon
IOCGE 2026
Session 8. Pharmacogenomics
Session 3. Microbial Genetics and Metagenomics
Date: 4 December 2026 (Friday)
Time: 15:00 (CET, Basel) | 09:00 (EST, New York) | 22:00 (CST Asia, Beijing)
| Time in CET | Speaker | Title |
Session 8. Pharmacogenomics |
||
| 15:00-15:05 | Prof. Dr. Henry H. Heng Session Chair |
Welcome from the Session Chair |
| 15:05–15:35 | Prof. Dr. Henry H. Heng Keynote Speaker |
Genome Chaos Drives Macroevolution: Implications and Challenges for Cancer Pharmacogenomics |
| 15:35-15:50 | Caroline Costa Mesquita Selected Speaker |
Do GLP1R and GIPR Variants Predict Response to Incretin-Based Therapies? A Systematic Review of Weight Loss, Glycaemic Efficacy, and Gastrointestinal Tolerability |
| 15:50-16:05 | Lilianna Mae Mora Selected Speaker |
Feasibility of CYP2C19 Pharmacogenomic-Guided Testing among Patients on Escitalopram: A Systematic Review and Pilot Study in Filipinos |
Session 3. Microbial Genetics and Metagenomics |
||
| 16:05-16:10 | Dr. Silvia Turroni Session Chair |
Welcome from the Session Chair |
| 16:10-16:40 | Dr. Silvia Turroni Keynote Speaker |
To be updated |
| 16:40-17:10 | Prof. Dr. Garth Ehrlich Keynote Speaker |
Using Machine Learning and Artificial Intelligence for Identification and Characterization of Bacterial Virulence Factors from within the Genomic Dark Matter |
| 17:10-17:25 | Rongzhen Dai Selected Speaker |
Genome size and annotation-parameter variability explain most apparent trophic-mode differences in prokaryotic biosynthetic gene cluster abundance |
| 17:25-17:40 | Savanah Senn Selected Speaker |
Integrating Long-Read Metagenomics and Soil Chemistry to Evaluate Sustainable Alternatives to Plastic Mulch |
| 17:40-17:55 | Esther Omobola Areo Selected Speaker |
Antimicrobial susceptibility, antimicrobial resistance and virulence genes of non-typhoidal Salmonella arizonae, Salmonella typhimurium, Salmonella enteritidis and Salmonella infantis isolated from fresh fruits and vegetables sold in Nigerian farmers’ markets |